Cryptococcosis is associated with high rates of morbidity and mortality, especially in AIDS
patients. Its treatment is carried out by combining amphotericin B and azoles or flucytosine …

Background Cryptococcus neoformans is a common human fungal pathogen in
immunocompromised people, as well as a prevalent cause of meningitis in HIV-infected …

Cryptococcus neoformans is a human-pathogenic yeast responsible for pneumonia and
meningitis, mainly in patients immunocompromised. Infections caused by C. neoformans are …

Cryptococcus neoformans, an opportunistic fungal pathogen, causes cryptococcosis in
immunocompromised persons. A series of modified L‐histidines‐containing peptides are …

Background Cryptococcosis and cryptococcal meningitis, caused by Cryptococcus
neoformans infections, lead to approximately 180,000 deaths per year, primarily in …

Cryptococcus neoformans is a fungal pathogen which causes nearly half a million deaths
worldwide each year. Under host-relevant conditions, it produces a characteristic …

The development of novel antifungal agents with high efficacy, low drug tolerance and few
side effects is urgent. MSI-1 (GIWKFLKKAKKFWK-NH 2), a cationic antimicrobial peptide …

Cryptococcus neoformans is an important opportunistic human fungal pathogen that causes
cryptococcosis in immunocompromised patients. However, the number of drugs for the …

The new structural classes of ultrashort peptides that exhibit potent microbicidal action have
potential as future drugs. Herein, we report that C-2 arylated histidines containing tripeptides …

There is a significant need for developing compounds that kill Cryptococcus neoformans, the
fungal pathogen that causes meningoencephalitis in immunocompromised individuals …